TY - JOUR
T1 - Supply of buprenorphine waivered physicians
T2 - The influence of state policies
AU - Stein, Bradley D.
AU - Gordon, Adam J.
AU - Dick, Andrew W.
AU - Burns, Rachel M.
AU - Pacula, Rosalie Liccardo
AU - Farmer, Carrie M.
AU - Leslie, Douglas L.
AU - Sorbero, Mark
N1 - Funding Information:
The authors are indebted to Steve Mason of SAMHSA and Lori Ducharme of NIDA for their assistance with this project, and Gina Boyd for research assistance and manuscript preparation. We gratefully acknowledge support for this work from the National Institute of Drug Abuse of the National Institutes of Health under Award Number R01DA032881-01A1. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Publisher Copyright:
© 2014 Elsevier Inc.
PY - 2015/1/1
Y1 - 2015/1/1
N2 - Buprenorphine, an effective opioid use disorder treatment, can be prescribed only by buprenorphine-waivered physicians. We calculated the number of buprenorphine-waivered physicians/100,000 county residents using 2008-11 Buprenorphine Waiver Notification System data, and used multivariate regression models to predict number of buprenorphine-waivered physicians/100,000 residents in a county as a function of county characteristics, state policies and efforts to promote buprenorphine use. In 2011, 43% of US counties had no buprenorphine-waivered physicians and 7% had 20 or more waivered physicians. Medicaid funding, opioid overdose deaths, and specific state guidance for office-based buprenorphine use were associated with more buprenorphine-waivered physicians, while encouraging methadone programs to promote buprenorphine use had no impact. Our findings provide important empirical information to individuals seeking to identify effective approaches to increase the number of physicians able to prescribe buprenorphine.
AB - Buprenorphine, an effective opioid use disorder treatment, can be prescribed only by buprenorphine-waivered physicians. We calculated the number of buprenorphine-waivered physicians/100,000 county residents using 2008-11 Buprenorphine Waiver Notification System data, and used multivariate regression models to predict number of buprenorphine-waivered physicians/100,000 residents in a county as a function of county characteristics, state policies and efforts to promote buprenorphine use. In 2011, 43% of US counties had no buprenorphine-waivered physicians and 7% had 20 or more waivered physicians. Medicaid funding, opioid overdose deaths, and specific state guidance for office-based buprenorphine use were associated with more buprenorphine-waivered physicians, while encouraging methadone programs to promote buprenorphine use had no impact. Our findings provide important empirical information to individuals seeking to identify effective approaches to increase the number of physicians able to prescribe buprenorphine.
UR - http://www.scopus.com/inward/record.url?scp=84922830146&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84922830146&partnerID=8YFLogxK
U2 - 10.1016/j.jsat.2014.07.010
DO - 10.1016/j.jsat.2014.07.010
M3 - Article
C2 - 25218919
AN - SCOPUS:84922830146
SN - 0740-5472
VL - 48
SP - 104
EP - 111
JO - Journal of Substance Abuse Treatment
JF - Journal of Substance Abuse Treatment
IS - 1
ER -
